Idiopathic pulmonary fibrosis: Difference between revisions
From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
(→) |
||
| Line 13: | Line 13: | ||
* CXR showing interstitial pattern |
* CXR showing interstitial pattern |
||
* PFTs showing low DLCO and FVC (i.e. a restrictive pattern |
* PFTs showing low DLCO and FVC (i.e. a restrictive pattern) |
||
* High-res CT scan showing a UIP pattern |
* High-res CT scan showing a UIP pattern |
||
** Subpleural/basal |
** Subpleural/basal |
||
** Reticulation |
|||
** reticulation |
|||
** Honeycombing |
** Honeycombing |
||
** No incosistent features |
** No incosistent features |
||
| Line 31: | Line 31: | ||
* Supplemental oxygen |
* Supplemental oxygen |
||
* Medications |
* Medications |
||
** Consider nintedanib and perfenidone |
** Consider [[nintedanib]] and [[perfenidone]] |
||
** Avoid prednisone and azathioprine |
** Avoid prednisone and azathioprine |
||
** NAC not helpful |
** NAC not helpful |
||
Latest revision as of 22:25, 12 January 2022
See also Interstitial lung disease
Definition
- Chronic idiopathic interstitial lung disease characterized by a usual interstitial pneumonia on histopathology
Clinical Manifestations
- Fine velcro-like crackles
- Clubbing
Investigations
- CXR showing interstitial pattern
- PFTs showing low DLCO and FVC (i.e. a restrictive pattern)
- High-res CT scan showing a UIP pattern
- Subpleural/basal
- Reticulation
- Honeycombing
- No incosistent features
- If high-res CT indeterminate, consider biopsy (but 5% mortality from biopsy in ILD)
- CBC, electrolytes
- ANA/ENA, RF, CCP
- Precipitating antibodies
Management
- Smoking cessation
- Vaccines: seasonal influenza and pneumococcal (13 then 23)
- Pulmonary rehab
- Supplemental oxygen
- Medications
- Consider nintedanib and perfenidone
- Avoid prednisone and azathioprine
- NAC not helpful
- Trial of GERD treatment even if asymptomatic
- Early antibiotics for respiratory infections
